Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Development in LGMD2i

NCT04202627 is registered in ClinicalTrials.gov with ML Bio Solutions, Inc. as lead sponsor.

NCT NCT04202627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04202627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Development in LGMD2i
Lead sponsor
ML Bio Solutions, Inc.
Phase
Observational
Overall status
Completed
Start date
December 1, 2019
Completion date
October 10, 2022
Enrollment
101 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

limb girdle muscular dystrophy, muscular dystrophies